67
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Suppression of lung cancer progression by biocompatible glycerol triacrylate–spermine-mediated delivery of shAkt1

, , , , , , , , , & show all
Pages 2293-2306 | Published online: 04 May 2012

References

  • McManusMTSharpPAGene silencing in mammals by small interfering RNAsNat Rev Genet200231073774712360232
  • KimSHMokHJeongJHComparative evaluation of target- specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugateBioconjug Chem200617124124416417275
  • JiangHLXuCXKimYKThe suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/ Akt1 shRNA complexes through the Akt signaling pathwayBiomaterials200930295844585219640582
  • AagaardLRossiJJRNAi therapeutics: principles, prospects and challengesAdv Drug Deliv Rev2007592–3758617449137
  • KimWJKimSWEfficient siRNA delivery with non-viral polymeric vehiclesPharm Res200926365766619015957
  • LuoDSaltzmanWMSynthetic DNA delivery systemsNat Biotechnol2000181333710625387
  • ElsabahyMNazaraliAFoldvariMNon-viral nucleic acid delivery: key challenges and future directionsCurr Drug Deliv20118323524421291381
  • MohammadiZAbolhassaniMDorkooshFAPreparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cellsInt J Pharm20114091–230731321356293
  • LungwitzUBreunigMBlunkTGopferichAPolyethylenimine-based non-viral gene delivery systemsEur J Pharm Biopharm200560224726615939236
  • BoussifOLezoualc’hFZantaMAMergnyMDSchermanDDemeneixBA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimineProc Natl Acad Sci U S A19959216729773017638184
  • BeyerleAIrmlerMBeckersJKisselTStoegerTToxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applicationsMol Pharm20107372773720429563
  • ChoiYJKangSJKimYJLimYBChungHWComparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cellsDrug Chem Toxicol201033435736620550436
  • JiangHLKimYKAroteRNahJWChoMHChoiYJChitosan- graft-polyethylenimine as a gene carrierJ Control Release2007117227328017166614
  • SinghRPDeepGChittezhathMEffect of silibinin on the growth and progression of primary lung tumors in miceJ Natl Cancer Inst2006981284685516788158
  • JiangHLLimHTKimYKChitosan-graft-spermine as a gene carrier in vitro and in vivoEur J Pharm Biopharm2011771364220932903
  • AllenJCBiochemistry of the polyaminesCell Biochem Funct1983131311406205785
  • KunathKvon HarpeAFischerDLow-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimineJ Control Release200389111312512695067
  • JiangHLKwonJTKimEMGalactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte- targetingJ Control Release2008131215015718706946
  • JiangHLKwonJTKimYKGalactosylated chitosangraft- polyethylenimine as a gene carrier for hepatocyte targetingGene Ther200714191389139817637795
  • GoodmanCMMcCuskerCDYilmazTRotelloVMToxicity of gold nanoparticles functionalized with cationic and anionic side chainsBioconjug Chem200415489790015264879
  • SchaeublinNMBraydich-StolleLKSchrandAMSurface charge of gold nanoparticles mediates mechanism of toxicityNanoscale20113241042021229159
  • BehrJPThe proton sponge: a trick to enter cells the viruses did not exploitChimia1997511–23436
  • SuhJPaikHJHwangBKIonization of poly (ethylenimine) and poly (allylamine) at various pH’sBioorg Chem1994223318327
  • PackDWHoffmanASPunSStaytonPSDesign and development of polymers for gene deliveryNat Rev Drug Discov20054758159316052241
  • KichlerALeborgneCCoeytauxEDanosOPolyethylenimine-mediated gene delivery: a mechanistic studyJ Gene Med20013213514411318112
  • PattonJSByronPRInhaling medicines: delivering drugs to the body through the lungsNat Rev Drug Discov200761677417195033
  • FerrariSGriesenbachUGeddesDMAltonEImmunological hurdles to lung gene therapyClin Exp Immunol200313211812653829
  • ZhouHSLiuDPLiangCCChallenges and strategies: the immune responses in gene therapyMed Res Rev200424674876115250039
  • DavidOAkt and PTEN: new diagnostic markers of non-small cell lung cancer?J Cell Mol Med20015443043312067477
  • YangJLiuXBhallaKPrevention of apoptosis by Bcl-2: release of cytochrome C from mitochondria blockedScience19972755303112911329027314
  • SánchezIDynlachtBDNew insights into cyclins, CDKs, and cell cycle controlSemin Cell Dev Biol200516331132115840440
  • MolinariMCell cycle checkpoints and their inactivation in human cancerCell Prolif200033526127411063129
  • DillonRLWhiteDEMullerWJThe phosphatidyl inositol 3-kinase signaling network: implications for human breast cancerOncogene20072691338134517322919
  • LeonardiEGirlandoSSerioGPCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variablesJ Clin Pathol19924554164191350788
  • JezierskaAMotylTMatrix metalloproteinase-2 involvement in breast cancer progression: a mini-reviewMed Sci Monit2009152RA324019182722
  • CurranSMurrayGIMatrix metalloproteinases in tumour invasion and metastasisJ Pathol1999189330030810547590
  • NiklińskaWBurzykowskiTChyczewskiLNiklinskiJExpression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosisLung Cancer200134Suppl 2S59S64
  • MineoTCAmbrogiVBaldiAPrognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancerJ Clin Pathol200457659159715166262